Organotics, a brain organoid startup, uses AI and patient-derived brain models to fast-track personalized medicine for autism and reduce psychiatric drug failure.

Shares of companies that conduct drug trials on behalf of pharmaceutical companies, such as Icon (ICLR), Iqvia (IQV), and Medpace (MEDP), are trading lower following a media report stating the Food ...

AI promised to speed up drug discovery, but the real bottleneck is in clinical trials. This startup is using AI to accelerate them.

A stylized image of Max Barnhart sitting on a chair with his arm on a pillow, receiving an IV infusion. The background is a grid containing a microscope image of malaria parasites flanked on each side ...

Outsourcing is driving biopharma efficiency and scale, including in the drug discovery area and early phase development.

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Roth believes that potential upside from clinical data expected later this year, combined with above-consensus expectations for its lead drug, could boost Insmed . The investment firm initiated the ...